In a statement, a spokesperson for UW-Madison said the university “does not yet have clarity on the full impacts of” the ruling, but that it “puts at risk” more than $14 million for biomedical research.
“This figure represents the remaining money on 22 grants that were already approved and underway, which also means the time and money already spent on these projects will potentially go to waste, in addition to the money that will not be recovered,” said UW-Madison spokesperson Victoria Comella.